ARCHIVES

Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.”

This article is from The Cancer Letter archive.

Vol. 30 No. 41 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

Phase II Study Finds Dasatinib May Overcome ALL Resistance

May 25, 2007

Sullivan Confirmation Hearing Set For Feb. 1

January 27, 1989

In Brief: Larry Kun Was Named Clinical Director and Executive Vice President of St. Jude Children’s Research Hospital

November 1, 2013

ACCC Annual Meeting Expands to 4 Days, One On Cancer Control

January 15, 1982

Harold Freeman To Direct NCI Center To Reduce Cancer Health Disparities.

September 15, 2000

Waxman Compromise Bill Clears House; Centers Line Item Traded For Guarantee Of Minimum Number of 55

November 25, 1983